Pain Reduction With Topical Bromfenac Versus Artificial Tear After Intravitreal Injection.

Completed · Phase 4

Conditions studied: Pain, Intravitreal Injection, Pain, Acute

In brief

The purpose of this prospective interventional study is to compare post-intravitreal injection pain between eyes receiving topical bromfenac versus artificial tears as an analgesic after intravitreal injection.

Key facts

Study ID

NCT06130384

Run by

Wills Eye

People needed

97

Starts

2021-03-01

Expected to finish

2023-11-15

Last updated by the study team

2024-02-09

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: accepted.

Where it is running

• Ophthalmic Consultants of Boston — Boston, Massachusetts, United States
• Mid Atlantic Retina — Bethlehem, Pennsylvania, United States
• Mid Atlantic Retina — Philadelphia, Pennsylvania, United States
• Retina Consultants of San Antonio — San Antonio, Texas, United States
• University of Toronto — Toronto, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.